 | LAE | Name: | 3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE | Formula: | C12 H19 N O4 | SMILES: | O=C1OCCC1NC(=O)CC(=O)CCCCC | InChi: | InChI=1S/C12H19NO4/c1-2-3-4-5-9(14)8-11(15)13-10-6-7-17-12(10)16/h10H,2-8H2,1H3,(H,13,15)/t10-/m0/s1 | Synonyms: | N-(3-OXO-OCTANAL-1-YL)-HOMOSERINE LACTONE | Definition date: | 2002-03-07 | Last modified: | 2020-06-17 | Identifier: | 3-oxo-N-[(3S)-2-oxotetrahydrofuran-3-yl]octanamide |
|
 | LAP | Name: | [2-((1-OXODODECANOXY-(2-HYDROXY-3-PROPANYL))-PHOSPHONATE-OXY)-ETHYL]-TRIMETHYLAMMONIUM | Formula: | C20 H43 N O7 P | SMILES: | O=C(OCC(O)COP(=O)(OCC[N+](C)(C)C)O)CCCCCCCCCCC | InChi: | InChI=1S/C20H42NO7P/c1-5-6-7-8-9-10-11-12-13-14-20(23)26-17-19(22)18-28-29(24,25)27-16-15-21(2,3)4/h19,22H,5-18H2,1-4H3/p+1 | Synonyms: | L-ALFA-LYSOPHOSPHATIDYLCHOLINE, LAUROYL | Definition date: | 2002-09-02 | Last modified: | 2020-06-17 | Identifier: | 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphahenicosan-1-aminium 4-oxide |
|
 | LAX | Name: | EICOSA-8,11,14-TRIENOIC ACID | Formula: | C20 H34 O2 | SMILES: | O=C(O)CCCCCCC=C/CC=C/CC=C/CCCCC | InChi: | InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12- | Synonyms: | DIHOMO-GAMMA-LINOLENIC ACID | Definition date: | 2000-08-10 | Last modified: | 2020-06-17 | Identifier: | (8Z,11Z,14Z)-icosa-8,11,14-trienoic acid |
|
 | LBN | Name: | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine | Formula: | C42 H82 N O8 P | SMILES: | C(C(COC(CCCCCCCCCCCCCCC)=O)OC(CCCCCCCC=[C@H]CCCCCCCC)=O)OP(OCC[N+](C)(C)C)([O-])=O | InChi: | InChI=1S/C42H82NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h20-21,40H,6-19,22-39H2,1-5H3/b21-20-/t40-/m1/s1 | Synonyms: | (2R)-2-[(9Z)-9-Octadecenoyloxy]-3-(palmitoyloxy)propyl 2-(trimethylammonio)ethyl phosphate | Definition date: | 2013-02-14 | Last modified: | 2020-06-17 | Release date: | 2020-01-08 | Identifier: | (2R)-3-(hexadecanoyloxy)-2-{[(9Z)-octadec-9-enoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate |
|
 | LCF | Name: | [6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YL]ACETIC ACID | Formula: | C23 H22 Cl N O2 | SMILES: | Clc4ccc(c1c(n3c(c1c2ccccc2)CC(C)(C3)C)CC(=O)O)cc4 | InChi: | InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27) | Synonyms: | LICOFELONE | Definition date: | 2005-06-14 | Last modified: | 2020-06-17 | Identifier: | [6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid |
|
 | LCR | Name: | (2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid | Formula: | C21 H25 Cl N2 O3 | SMILES: | O=C(O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3 | InChi: | InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)/t21-/m1/s1 | Synonyms: | R-levocetirizine | Definition date: | 2015-09-16 | Last modified: | 2020-06-17 | Release date: | 2015-12-23 | Identifier: | (2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid |
|
 | LDC | Name: | 4-AMINO-1-(2-DEOXY-BETA-L-ERYTHRO-PENTOFURANOSYL)PYRIMIDIN-2(1H)-ONE | Formula: | C9 H13 N3 O4 | SMILES: | O=C1N=C(N)C=CN1C2OC(C(O)C2)CO | InChi: | InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m1/s1 | Synonyms: | L-2'-DEOXYCYTIDINE | Definition date: | 2006-10-26 | Last modified: | 2020-06-17 | Identifier: | 4-amino-1-(2-deoxy-beta-L-erythro-pentofuranosyl)pyrimidin-2(1H)-one |
|
 | LDM | Name: | 3-LAURYLAMIDO-N,N'-DIMETHYLPROPYLAMINOXYDE | Formula: | C17 H36 N2 O2 | SMILES: | [O-][N+](C)(CCCNC(=O)CCCCCCCCCCC)C | InChi: | InChI=1S/C17H36N2O2/c1-4-5-6-7-8-9-10-11-12-14-17(20)18-15-13-16-19(2,3)21/h4-16H2,1-3H3,(H,18,20) | Synonyms: | [3-(DODECANOYLAMINO)PROPYL](HYDROXY)DIMETHYLAMMONIUM | Definition date: | 2003-07-21 | Last modified: | 2020-06-17 | Identifier: | N-[3-(dimethylnitroryl)propyl]dodecanamide |
|
 | LDP | Name: | L-DOPAMINE | Formula: | C8 H11 N O2 | SMILES: | Oc1ccc(cc1O)CCN | InChi: | InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2 | Synonyms: | DOPAMINE | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | 4-(2-aminoethyl)benzene-1,2-diol |
|
 | LEV | Name: | 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide | Formula: | C21 H19 Cl N4 O4 | SMILES: | COc2cc1nccc(c1cc2C(N)=O)Oc3cc(c(cc3)NC(=O)NC4CC4)Cl | InChi: | InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28) | Synonyms: | lenvatinib | Definition date: | 2014-09-26 | Last modified: | 2020-06-17 | Release date: | 2015-05-27 | Identifier: | 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide |
|
 | LFF | Name: | (2S)-3-[(R)-{(1R)-1-[(N-acetyl-L-leucyl)amino]-2-phenylethyl}(hydroxy)phosphoryl]-2-benzylpropanoic acid | Formula: | C26 H35 N2 O6 P | SMILES: | O=C(O)C(Cc1ccccc1)CP(=O)(O)C(NC(=O)C(NC(=O)C)CC(C)C)Cc2ccccc2 | InChi: | InChI=1S/C26H35N2O6P/c1-18(2)14-23(27-19(3)29)25(30)28-24(16-21-12-8-5-9-13-21)35(33,34)17-22(26(31)32)15-20-10-6-4-7-11-20/h4-13,18,22-24H,14-17H2,1-3H3,(H,27,29)(H,28,30)(H,31,32)(H,33,34)/t22-,23+,24-/m1/s1 | Synonyms: | ACETYL-LEU-PHE-Y(PO2CH2)-PHE-OH | Definition date: | 2014-12-23 | Last modified: | 2020-06-17 | Release date: | 2016-01-20 | Identifier: | (2S)-3-[(R)-{(1R)-1-[(N-acetyl-L-leucyl)amino]-2-phenylethyl}(hydroxy)phosphoryl]-2-benzylpropanoic acid |
|
 | LG4 | Name: | 5-METHYLPYRIDIN-2-AMINE | Formula: | C6 H8 N2 | SMILES: | n1cc(ccc1N)C | InChi: | InChI=1S/C6H8N2/c1-5-2-3-6(7)8-4-5/h2-4H,1H3,(H2,7,8) | Synonyms: | 2-AMINO-5-PICOLINE | Definition date: | 2005-11-08 | Last modified: | 2020-06-17 | Identifier: | 5-methylpyridin-2-amine |
|
 | LGB | Name: | 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-met
hylbenzonitrile | Formula: | C15 H13 Cl F3 N3 O2 | SMILES: | N#Cc3ccc(/N=C1OC(C(F)(F)F)C2N1CCC2O)c(c3Cl)C | InChi: | InChI=1S/C15H13ClF3N3O2/c1-7-9(3-2-8(6-20)11(7)16)21-14-22-5-4-10(23)12(22)13(24-14)15(17,18)19/h2-3,10,12-13,23H,4-5H2,1H3/b21-14-/t10-,12-,13+/m0/s1 | Synonyms: | 3,11-DIFLUORO-6,8,13-TRIMETHYL-8H-QUINO[4,3,2-KL]ACRIDIN-13-IUM | Definition date: | 2009-01-30 | Last modified: | 2020-06-17 | Identifier: | 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile |
|
 | LGP | Name: | N9-1-HYDROXY-PROP-2-OXYMETHYL-GUANINE-3'-MONOPHOSPHATE | Formula: | C9 H14 N5 O7 P | SMILES: | O=P(O)(O)OCC(OCn1c2N=C(NC(=O)c2nc1)N)CO | InChi: | InChI=1S/C9H14N5O7P/c10-9-12-7-6(8(16)13-9)11-3-14(7)4-20-5(1-15)2-21-22(17,18)19/h3,5,15H,1-2,4H2,(H2,17,18,19)(H3,10,12,13,16)/t5-/m0/s1 | Synonyms: | LINEAR DECARBON-C2* GUANOSINE-5'-MONOPHOSPHATE | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | (2S)-2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl dihydrogen phosphate |
|
 | LGZ | Name: | CARBAMIC ACID 1-{5-BENZYL-5-[2-HYDROXY-4-PHENYL-3-(TETRAHYDRO-FURAN-
3-YLOXYCARBONYLAMINO)-BUTYL]-4-OXO-4,5-DIHYDRO-1H-PYRROL-3-YL}- INDAN-2-YL ESTER | Formula: | C36 H39 N3 O7 | SMILES: | O=C(OC1CCOC1)NC(Cc2ccccc2)C(O)CC3(C(=O)C(=CN3)C5c4ccccc4CC5OC(=O)N)Cc6ccccc6 | InChi: | InChI=1S/C36H39N3O7/c37-34(42)46-31-18-25-13-7-8-14-27(25)32(31)28-21-38-36(33(28)41,19-24-11-5-2-6-12-24)20-30(40)29(17-23-9-3-1-4-10-23)39-35(43)45-26-15-16-44-22-26/h1-14,21,26,29-32,38,40H,15-20,22H2,(H2,37,42)(H,39,43)/t26-,29+,30+,31-,32-,36+/m1/s1 | Synonyms: | LGZ479 INHIBITOR | Definition date: | 2003-01-21 | Last modified: | 2020-06-17 | Identifier: | (3R)-tetrahydrofuran-3-yl [(1S,2S)-1-benzyl-3-{(2S)-2-benzyl-4-[(1R,2R)-2-(carbamoyloxy)-2,3-dihydro-1H-inden-1-yl]-3-oxo-2,3-dihydro-1H-pyrrol-2-yl}-2-hydroxypropyl]carbamate |
|
 | LHA | Name: | DOUBLY FUNCTIONALIZED PAROMOMYCIN PM-II-162 | Formula: | C37 H65 N7 O16 | SMILES: | O=C(NC5C(O)C(OC3OC(C(OC1OC(CN)C(O)C(O)C1N)C3OCCNCCc2ccccc2)CO)C(OC4OC(CO)C(O)C(O)C4N)C(N)C5)C(O)CCN | InChi: | InChI=1S/C37H65N7O16/c38-8-6-19(47)34(53)44-18-12-17(40)30(58-36-24(42)29(52)27(50)21(14-45)56-36)32(25(18)48)60-37-33(54-11-10-43-9-7-16-4-2-1-3-5-16)31(22(15-46)57-37)59-35-23(41)28(51)26(49)20(13-39)55-35/h1-5,17-33,35-37,43,45-52H,6-15,38-42H2,(H,44,53)/t17-,18+,19-,20-,21+,22+,23+,24+,25-,26+,27+,28+,29+,30+,31+,32+,33+,35+,36+,37-/m0/s1 | Synonyms: | (2S)-4-AMINO-N-[(1R,2S,3R,4R,5S)-5-AMINO-4-[(2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-3-{[3-O-(2,6-DIAMINO-2,6-DIDEO
XY-BETA-L-IDOPYRANOSYL)-2-O-{2-[(2-PHENYLETHYL)AMINO]ETHYL}-BETA-D-RIBOFURANOSYL]OXY}-2-HYDROXYCYCLOHEXYL]-2-HYDROXYBUTA
NAMIDE | Definition date: | 2007-06-05 | Last modified: | 2020-06-17 | Identifier: | (2S)-4-amino-N-[(1R,2S,3R,4R,5S)-5-amino-4-[(2-amino-2-deoxy-alpha-D-glucopyranosyl)oxy]-3-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-2-O-{2-[(2-phenylethyl)amino]ethyl}-beta-D-ribofuranosyl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanamide |
|
 | LIC | Name: | 3-(2-CHLOROBENZYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA | Formula: | C24 H28 Cl N5 O3 | SMILES: | Clc1ccccc1CNC(=O)N(c2nc(ncc2)NC(C(O)(C)C)C)c3ccc(OC)cc3 | InChi: | InChI=1S/C24H28ClN5O3/c1-16(24(2,3)32)28-22-26-14-13-21(29-22)30(18-9-11-19(33-4)12-10-18)23(31)27-15-17-7-5-6-8-20(17)25/h5-14,16,32H,15H2,1-4H3,(H,27,31)(H,26,28,29)/t16-/m0/s1 | Synonyms: | 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE | Definition date: | 2006-03-29 | Last modified: | 2020-06-17 | Identifier: | 3-(2-chlorobenzyl)-1-(2-{[(1S)-2-hydroxy-1,2-dimethylpropyl]amino}pyrimidin-4-yl)-1-(4-methoxyphenyl)urea |
|
 | LIF | Name: | N-{4-[4-AMINO-6-(4-METHOXYPHENYL)FURO[2,3-D]PYRIMIDIN-5-YL]PHENYL}-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA | Formula: | C27 H19 F4 N5 O3 | SMILES: | FC(F)(F)c1cc(c(F)cc1)NC(=O)Nc5ccc(c2c4c(ncnc4oc2c3ccc(OC)cc3)N)cc5 | InChi: | InChI=1S/C27H19F4N5O3/c1-38-18-9-4-15(5-10-18)23-21(22-24(32)33-13-34-25(22)39-23)14-2-7-17(8-3-14)35-26(37)36-20-12-16(27(29,30)31)6-11-19(20)28/h2-13H,1H3,(H2,32,33,34)(H2,35,36,37) | Synonyms: | N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA | Definition date: | 2005-02-22 | Last modified: | 2020-06-17 | Identifier: | 1-{4-[4-amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea |
|
 | LIS | Name: | (2S,4S)-2-AMINO-4,5-EPOXIPENTANOIC ACID | Formula: | C5 H9 N O3 | SMILES: | O=C(O)C(N)CC1OC1 | InChi: | InChI=1S/C5H9NO3/c6-4(5(7)8)1-3-2-9-3/h3-4H,1-2,6H2,(H,7,8)/t3-,4-/m0/s1 | Synonyms: | 3-OXIRAN-2YLALANINE | Definition date: | 2002-12-10 | Last modified: | 2020-06-17 | Identifier: | (2S)-2-amino-3-[(2S)-oxiran-2-yl]propanoic acid (non-preferred name) |
|
 | LIV | Name: | (2R,3S,4S,5S,6R)-2-((2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3S,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-DIAMINO-2-((2S,3R
,5S,6R)-3-AMINO-5-HYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-4-HYDROXY-2-(HYDROXYMET
HYL)-TETRAHYDROFURAN-3-YLOXY)-4-HYDROXY-TETRAHYDRO-2H-PYRAN-3-YLOXY)-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL | Formula: | C29 H55 N5 O18 | SMILES: | O(C2C(OC1OC(CO)C(O)CC1N)C(N)CC(N)C2O)C5OC(C(OC4OC(CN)C(OC3OC(CO)C(O)C(O)C3O)C(O)C4N)C5O)CO | InChi: | InChI=1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1 | Synonyms: | LIVIDOMYCIN A | Definition date: | 2005-11-16 | Last modified: | 2020-06-17 | Identifier: | (1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-{[alpha-D-mannopyranosyl-(1->4)-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl]oxy}cyclohexyl 2-amino-2,3-dideoxy-alpha-D-ribo-hexopyranoside |
|
 | LJ1 | Name: | 2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol | Formula: | C16 H16 O | SMILES: | Oc2c(cc(C=Cc1ccccc1)cc2C)C | InChi: | InChI=1S/C16H16O/c1-12-10-15(11-13(2)16(12)17)9-8-14-6-4-3-5-7-14/h3-11,17H,1-2H3/b9-8+ | Synonyms: | 3,5-Dimethyl-4-hydroxystilbene | Definition date: | 2008-03-25 | Last modified: | 2020-06-17 | Identifier: | 2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol |
|
 | LJ3 | Name: | 3,5-dibromobiphenyl-4-ol | Formula: | C12 H8 Br2 O | SMILES: | Brc1cc(cc(Br)c1O)c2ccccc2 | InChi: | InChI=1S/C12H8Br2O/c13-10-6-9(7-11(14)12(10)15)8-4-2-1-3-5-8/h1-7,15H | Synonyms: | 3,5-Dibromo-4-hydroxybiphenyl | Definition date: | 2008-03-25 | Last modified: | 2020-06-17 | Identifier: | 3,5-dibromobiphenyl-4-ol |
|
 | LJ4 | Name: | 2,6-dibromo-4-phenoxyphenol | Formula: | C12 H8 Br2 O2 | SMILES: | Brc2cc(Oc1ccccc1)cc(Br)c2O | InChi: | InChI=1S/C12H8Br2O2/c13-10-6-9(7-11(14)12(10)15)16-8-4-2-1-3-5-8/h1-7,15H | Synonyms: | 1,3-Dibromo-2-hydroxy-5-phenoxybenzene | Definition date: | 2008-03-25 | Last modified: | 2020-06-17 | Identifier: | 2,6-dibromo-4-phenoxyphenol |
|
 | LL2 | Name: | 5-benzyl-1,3-thiazol-2-amine | Formula: | C10 H10 N2 S | SMILES: | n1cc(sc1N)Cc2ccccc2 | InChi: | InChI=1S/C10H10N2S/c11-10-12-7-9(13-10)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H2,11,12) | Synonyms: | 5-Benzyl-thiazol-2-ylmaine | Definition date: | 2008-07-03 | Last modified: | 2020-06-17 | Identifier: | 5-benzyl-1,3-thiazol-2-amine |
|
 | H4C | Name: | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6,8-dihydrothieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-10-ium | Formula: | C17 H16 Cl N4 S | SMILES: | Clc4ccccc4C2=NCc1nnc([n+]1c3sc(cc23)CC)C | InChi: | InChI=1S/C17H15ClN4S/c1-3-11-8-13-16(12-6-4-5-7-14(12)18)19-9-15-21-20-10(2)22(15)17(13)23-11/h4-8H,3,9H2,1-2H3/p+1 | Synonyms: | 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetraazatricyclo trideca-2(6),4,7,10,12-pentaene | Definition date: | 2013-09-17 | Last modified: | 2020-06-17 | Release date: | 2013-10-02 | Identifier: | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6,8-dihydrothieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-10-ium |
|